In 2023, the import of heterocyclic compounds with unfused pyridine rings to India was valued at $368.28 million. The projected forecasts from 2024 to 2028 show a consistent annual growth, starting from $384.2 million in 2024 and reaching $443.69 million by 2028. Observing the year-on-year variations, the import value is expected to grow approximately 4% each year. The compound annual growth rate (CAGR) over this five-year period stands at approximately 3.8%.
Future trends to watch for include geopolitical developments affecting trade, changes in pharmaceutical demand worldwide, and potential shifts in India's chemical manufacturing policies, all of which could influence these import forecasts significantly.
